Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
ARTICLE

AMPA Receptor Activates a G-Protein that Suppresses a cGMP-Gated Current

Fusao Kawai and Peter Sterling
Journal of Neuroscience 15 April 1999, 19 (8) 2954-2959; https://doi.org/10.1523/JNEUROSCI.19-08-02954.1999
Fusao Kawai
1Department of Neuroscience, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6058, and
2Department of Information Physiology, National Institute for Physiological Sciences, Okazaki 444, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Sterling
1Department of Neuroscience, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6058, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The AMPA receptor, ubiquitous in brain, is termed “ionotropic” because it gates an ion channel directly. We found that an AMPA receptor can also modulate a G-protein to gate an ion channel indirectly. Glutamate applied to a retinal ganglion cell briefly suppresses the inward current through a cGMP-gated channel. AMPA and kainate also suppress the current, an effect that is blocked both by their general antagonist CNQX and also by the relatively specific AMPA receptor antagonist GYKI-52466. Neither NMDA nor agonists of metabotropic glutamate receptors are effective. The AMPA-induced suppression of the cGMP-gated current is blocked when the patch pipette includes GDP-β-S, whereas the suppression is irreversible when the pipette contains GTP-γ-S. This suggests a G-protein mediator, and, consistent with this, pertussis toxin blocks the current suppression. Nitric oxide (NO) donors induce the current suppressed by AMPA, and phosphodiesterase inhibitors prevent the suppression. Apparently, the AMPA receptor can exhibit a “metabotropic” activity that allows it to antagonize excitation evoked by NO.

  • AMPA
  • glutamate
  • ionotropic
  • metabotropic
  • G-protein
  • retina
  • rat

Glutamate, the major excitatory transmitter in brain, activates a class of receptors termed “ionotropic” because they directly gate ion channels (Nakanishi, 1992; Seeburg, 1993; Hille, 1994; Riedel, 1996; Pass, 1998). Recently, an ionotropic glutamate receptor of the subclass that binds AMPA was discovered in cortical homogenates to also have a “metabotropic” function: it activates a G-protein to suppress adenylyl cyclase (Wang et al., 1997). We wondered whether the AMPA receptor has other metabotropic functions and whether these might include indirect gating of ion channels. We thought to probe for a metabotropic effect in a system suited for subsequent investigation of its role in neural integration.

We chose the retinal ganglion cell because the effects of stimulating its dendritic AMPA receptors can be investigated in a slice preparation (Aizenman et al., 1988; Mittman et al., 1990; Cohen et al., 1994;Leinders-Zufall et al., 1994; Taylor et al., 1995; Zhang et al., 1995;Coleman and Miller, 1998; Matsui et al., 1998) and because the role in neural integration could then be investigated in the intact retinain vitro. Certain ganglion cells express a cGMP-gated channel that causes an inward current when nitric oxide (NO) stimulates guanylyl cyclase to raise [cGMP] (Ahmad et al., 1994). The natural source of NO is probably a class of amacrine cell that stains intensely for NADPH diaphorase (NO synthase) (Sandell, 1985; Sager, 1986). Reasoning that a current stimulated by one signal (NO) ought to be antagonized by another, we tested the AMPA receptor and discovered that in retinal ganglion cells it can activate a G-protein to suppress the cGMP-gated current.

MATERIALS AND METHODS

Preparation and recording. Slices from adult rat retina were cut at 200 μm (Werblin, 1978) and viewed on a Zeiss (Oberkochen, Germany) upright microscope with differential interference contrast optics (×40 water-immersion objective). Ganglion cells were identified in the slice by their position and size. Membrane currents were recorded in the whole-cell configuration (Hamill et al., 1981) using a patch-clamp amplifier (Axopatch 200A; Axon Instruments, Foster City, CA) linked to a computer. The voltage-clamp procedures were controlled by the pClamp software (Axon Instruments). Data were low-pass filtered (four-pole Bessel type) with a cutoff frequency of 5 kHz and then digitized at 10 kHz by an analog-to-digital interface. All experiments were performed at room temperature (23–25°C).

Solutions and drugs. The control Ringer’s solution contained (in mm): NaCl, 135; KCl, 5; CaCl2, 1; MgCl2, 1; HEPES, 10; and glucose, 10. The solution was adjusted with NaOH to pH 7.4 and bubbled with oxygen. CoCl2 (1 mm), picrotoxin (100 μm), and strychnine (1 μm) were also added to block synaptic transmission. The recording pipette contained (in mm): CsCl, 140; CaCl2, 1; EGTA or BAPTA, 5; HEPES, 10; and Mg-ATP, 2. The solution was adjusted with CsOH to pH 7.4. Pipette resistance was ∼7 MΩ.

Test substances were applied through the bath [8-bromo-cGMP, 8-bromo-cAMP, 8-p-chlorophenylthio-cGMP, CNQX, GYKI-52466, α-methyl-4-caboxyphenylglycine (MCPG), α-cyclopropyl-4-phosphonophenylglycine (CPPG), 1-methyl-3-isobutylxanthine (IBMX), zaprinast, methylene blue, or sodium nitroprusside], via pressure ejection for 1 sec from a “puffer” pipette (glutamate, AMPA, kainate, NMDA,l-2-amino-4-phosphonobutyrate [l-AP-4], or 1S,3R-1-aminocyclopentane-trans-1,3-dicarboxylic acid [trans-(1S,3R)-ACPD]), or via the patch pipette (cGMP, GTP-γ-S, GDP-β-S, pertussis toxin, or cholera toxin). MCPG and CPPG were purchased from Tocris Cookson (Ballwin, MO). Other chemicals were from Sigma (St. Louis, MO).

RESULTS

Recording from ganglion cells in the slice preparation of adult rat retina, we confirmed the observations of Ahmad et al. (1994) that certain ganglion cells express a cGMP-gated current. When a membrane-permeant analog of cGMP (8-bromo-cGMP) was bath-applied at 1 mm to a ganglion cell voltage-clamped at −50 mV, there was a sustained inward current (217 ± 6 pA; mean ± SEM) (Fig.1a). This current disappeared in normal Ringer’s solution. The same current was obtained with another membrane-permeant analog of cGMP [1 mm8-p-chlorophenylthio-cGMP, which strongly resists hydrolysis by phosphodiesterase (PDE)] in the bath and also when the recording pipette contained cGMP (Fig. 1d). A permeant analog of cAMP was ineffective (n = 4). The cGMP-gated current was observed in approximately half of the cells (37 of 73).

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Stimulation of an AMPA receptor reduced a sustained inward current caused by cGMP. a,b, Puffer application of 100 μm glutamate for 1 sec (thin arrows) or 100 μm AMPA induced a fast transient inward current. Superfusion with 1 mm 8-bromo-cGMP (bars) activated a sustained inward current that was reduced (thick arrows) by puffer application of glutamate or AMPA. c, Application of 100 μm AMPA failed to reduce the 8-bromo-cGMP-induced sustained current in the solution containing 100 μm CNQX.d, Intracellular dialysis with 1 mm cGMP caused a slowly developing inward current that was also reduced (thick arrow) by puffer application of 100 μm AMPA. Whole-cell recording established att = 0. e, Normalized responses to AMPA application plotted from b and d on a faster scale. All cells were held at −50 mV.

When the sustained cGMP-gated current was induced by 8-bromo-cGMP, a puff of 100 μm glutamate evoked a biphasic response (Fig.1a). First, there was a transient inward current, as expected for direct gating of an ionotropic receptor; then, there was a brief reduction of the sustained inward current (41 ± 7%;n = 5) (Fig. 1a). The same biphasic response was evoked by AMPA (10–100 μm) (Fig. 1b) and by the AMPA receptor agonist kainate (10 μm;n = 3). The amplitude of the second phase (reduced inward current) was similar for 100 μm AMPA and 10 μm kainate (38 ± 6 and 34 ± 11%, respectively, with 8-bromo-cGMP). The amplitude of the second phase was also similar for 100 μm by AMPA and 100 μmglutamate (54 ± 7 and 55 ± 8%, respectively, with cGMP). However, when the sustained inward current was induced by 8-p-chlorophenylthio-cGMP, 100 μm AMPA did not reduce the second phase of the response (3 ± 1%;n = 3). The reduction by AMPA of the inward current was faster (Fig. 1e, thick arrow) when the sustained current was induced by cGMP rather than by 8-bromo-cGMP. The latency to maximal reduction after the AMPA puff was 4 ± 2 sec for cGMP and 11 ± 3 sec for 8-bromo-cGMP.

To identify which type of glutamate receptor reduced the inward current, we applied various agonists and antagonists of the ionotropic receptors. CNQX (100 μm), an antagonist of both AMPA and kainate subtypes, diminished the effect of AMPA (n = 4) (Fig. 1c). Furthermore, GYKI-52466 (100 μm), a specific antagonist of the AMPA receptor (Donevan and Rogawski, 1993), also diminished the effect of kainate (n = 3). Therefore, kainate receptors are probably not involved. The AMPA effects observed here, both the conventional transient inward current and the novel reduction of the sustained inward current, seem to desensitize rather little, as reported by others for AMPA responses of bipolar and ganglion cells in mammalian retina (Cohen et al., 1994;Sasaki and Kaneko, 1996). Finally, NMDA, applied as a 100 μm puff, evoked a monophasic inward current but did not reduce the inward current (n = 4) (Fig.2a). Thus, whatever causes this brief reduction of the inward current, it is apparently triggered specifically by the AMPA receptor.

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

The sustained inward current caused by cGMP was unaffected by NMDA and mGluR agonists. a, Application of 100 μm NMDA for 1 sec from a puffer pipette (arrows) failed to reduce the 8-bromo-cGMP-induced sustained current. b, Application of 100 μml-AP-4 (arrows) had no effect on a cell before or during superfusion of 1 mm8-bromo-cGMP. All cells were held at −50 mV.

To test whether a metabotropic glutamate receptor (mGluR) might reduce the inward current, we applied mGluR agonists. These includedl-AP-4 (n = 4) (Fig. 2b) and ACPD (n = 3). Although these compounds evoke large currents in ON bipolar cells (Nawy and Jahr, 1990; Shiells and Falk, 1990; Yamashita and Wässle, 1991; Tian and Slaughter, 1994) at the concentration used (100 μm), they did not affect the inward cGMP-gated current. Furthermore, mGluR antagonists MCPG and CPPG, both applied at 300 μm, did not affect the AMPA-evoked reduction of the steady inward current (n = 4). We conclude that the reduction by AMPA of the sustained inward current is not caused by activation of an mGluR.

If the reduction by AMPA of the sustained inward current results from closing the cGMP-gated channel, both the reduction and the sustained current should have the same reversal potential. The reduction by AMPA of the sustained inward current was outward at negative potentials and reversed at 0 mV (Fig. 3b). Similarly, the sustained current induced by 8-bromo-cGMP was inward at negative potentials and also reversed at approximately 0 mV (Fig.3b). Similar values were obtained from four cells (3 ± 4 mV), consistent with a previous report (Ahmad et al., 1994). Thus, both the cGMP-gated current and its AMPA-induced reduction reversed at the same membrane potential (n = 4) (Fig.3c), suggesting that AMPA suppresses the cGMP-gated current. If so, AMPA should also suppress the sustained cGMP-gated current induced by the NO donor, sodium nitroprusside, and we confirmed this (n = 4) (Fig. 4).

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

AMPA-induced reduction of current reversed at the same potential as the cGMP-gated current. a, Brief current evoked by a puff of 100 μm AMPA was inward at negative potentials and reversed at 0 mV. b, Same cell in Ringer’s solution containing 1 mm 8-bromo-cGMP. Slow transient current evoked by AMPA was outward at negative potentials and reversed at 0 mV. c, I–V curves of the steady and reduced cGMP-gated currents. Both currents reversed at 2 mV. These experiments suggest that AMPA actually suppresses the cGMP-gated current.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Superfusion with 100 μm sodium nitroprusside (SNP) activated a sustained inward current reduced by puffer application of 100 μm AMPA for 1 sec (arrows). A cell was held at −50 mV.

To investigate how the AMPA receptor suppresses the cGMP-gated current, we considered a role for Ca2+ as a second messenger (Kaupp and Koch, 1992; Nakanishi, 1992; Hille, 1994; Koutalos and Yau, 1996). If Ca2+ entering through the AMPA receptor was involved, removing extracellular Ca2+ should abolish the suppression. However, with 5 mm EGTA or BAPTA in a recording pipette, AMPA puffed onto a ganglion cell in Ca2+-free Ringer’s solution evoked the usual suppression of the cGMP-gated current (n = 6) (Fig.5a). AMPA (100 μm) reduced the current by 41 ± 7%, which was similar to that in control Ringer’s solution (38 ± 6%). The latency (12 ± 4 sec) to maximal current reduction after the AMPA puff was also similar to the control (11 ± 3 sec). When all permeant cations were removed from the medium, 8-bromo-cGMP induced no inward current at negative potentials; however, it did induce a sustained outward current at positive potentials, and this current was suppressed by AMPA. Thus, neither Ca2+ nor Na+ influx is required for the suppression, and we sought another mechanism.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

The suppression by AMPA of the cGMP-gated current is mediated by a G-protein that activates PDE. a, Application of 100 μm AMPA (arrows) suppressed the 8-bromo-cGMP-induced sustained current in the Ca2+-free solution. The recording pipette contained 5 mm EGTA. b, Dialysis of a cell with 1 mm cGMP and 100 μm GTP-γ-S produced an inward current. An AMPA puff (arrow) evoked a brief inward current and suppressed the sustained inward current irreversibly. Whole-cell recording established at t= 0. c, Dialysis of a cell with pertussis toxin (PTX; 1 μg/ml) and NAD+ (1 mm) also produced an inward current. An AMPA puff (arrow) evoked a brief inward current but failed to suppress the sustained inward current. d, Superfusion with 100 μm IBMX (bar) activated an inward current. An AMPA puff (arrows) also failed to suppress the inward current induced by IBMX. All cells were held at −50 mV.

We considered a role for a G-protein, possibly the Gifamily (Gi or Go), because AMPA can stimulate Gi (Wang et al., 1997) and because the inner plexiform and ganglion cell layers are immunoreactive for Gi/o (Terashima et al., 1987; Vardi et al., 1993; Oguni et al., 1996). To test for a G-protein activity, we used 1 mmcGMP in the patch pipette to cause a sustained inward current (as in Fig. 1d) but also included 100 μm GTP-γ-S. An AMPA puff induced the expected inward transient, followed by suppression of the sustained current. However, when the AMPA dissipated, the sustained current was not restored; rather, the suppression became essentially irreversible (n = 4) (Fig. 5b). This would be expected if an activated G-protein had bound GTP-γ-S because this GTP analog does not hydrolyze. In a separate experiment with 1 mm cGMP in the pipette, we used 500 μm GDP-β-S to competitively block G-protein activation (Nawy and Jahr, 1990). This produced a sustained inward current, which AMPA failed to suppress (n = 3).

Evidence that the G-protein species might be Gi/o came from experiments with pertussis toxin. Pertussis toxin ADP ribosylates Gi/o (Milligan, 1988), thereby blocking its downstream effect. Dialyzing a cell with pertussis toxin and NAD+ (omitting cGMP) produced a sustained inward current, which AMPA also failed to suppress (n = 5) (Fig. 5c). When NAD+ was omitted, pertussis toxin alone failed to produce the effect (n = 3), suggesting that ADP-ribosylation by pertussis toxin of Gi/o induced the inward current. This effect of pertussis toxin is consistent with previous results with ON bipolar cell (Shiells and Falk, 1992). Cholera toxin, which ADP ribosylates Gs, caused no inward current until 8-bromo-cGMP was added, and then the usual suppression was observed (n = 3). Because the cGMP-gated current seems to be suppressed by activating Gi/o, we considered possible intermediate effectors.

PDE seemed a natural candidate, by analogy with photoreceptors and certain bipolar cells in which a G-protein activates PDE to suppress a cGMP-gated current (Yau and Baylor, 1989; Kaupp and Koch, 1992; Lamb and Pugh, 1992; Koutalos and Yau, 1996). Furthermore, as noted, suppression by AMPA of the inward current was faster when the sustained current was induced by cGMP rather than by 8-bromo-cGMP (Fig.1e). This would be expected from a PDE mechanism because the brominated analog hydrolyzes slowly (Wei et al., 1998). The amplitude of the current suppression was approximately similar for both compounds. Although this might seem contradictory, the sluggish hydrolysis of PDE of 8-bromo-cGMP may be counterbalanced by its sixfold higher affinity for 8-bromo versus native cGMP (Wei et al., 1998). These considerations led us to try inhibitors of PDE.

We found, as first reported by Ahmad et al. (1994), that the PDE inhibitor IBMX induced a sustained inward current in a ganglion cell that expresses the cGMP-gated channel (n = 4) (Fig.5d). This implies that the cell also expresses an active PDE that regulates intracellular cGMP. With IBMX in the bath, an AMPA puff failed to suppress the inward current (n = 4) (Fig.5d). We obtained the same result using a selective inhibitor of cGMP phosphodiesterase, zaprinast (n = 3). Presumably AMPA was ineffective because Gi/o could not activate PDE. The suppression by AMPA of the cGMP-gated current was observed when, to the bath containing 8-bromo-cGMP, we added 1 mm methylene blue, which completely inhibits guanylyl cyclase (n = 4) (Danziger et al., 1993; Fratelli et al., 1995; Stuart-Smith et al., 1998). This result suggests that the suppression does not involve modulation of the cyclase.

DISCUSSION

In ganglion cells that express the cGMP-gated channel, AMPA acts in two ways: (1) transiently opens a cation channel; and (2) activates a G-protein that, via PDE, reduces [cGMP] to suppress a cGMP-gated current (Fig. 6). This second effect of AMPA cannot be attributed to activation of a genuine mGluR receptor because agonists and antagonists of mGluRs were ineffective. We feel confident that a PDE is involved because the effect was abolished by inhibitors of PDE and also by the analog of cGMP, which strongly resists hydrolysis. In short, this AMPA receptor seems to exhibit both ionotropic and metabotropic activities. This conclusion fits biochemical evidence that an AMPA receptor in cortex can activate a G-protein to modulate cAMP (Wang et al., 1997) and that a kainate receptor in hippocampus can activate a G-protein to modulate yet another biochemical cascade (phospholipase C; Rodriguez-Moreno and Lerma, 1998). Thus, metabotropic effects of ionotropic glutamate receptors may prove to be both widespread and diverse.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Model explains how the AMPA receptor in retinal ganglion cells might suppress the cGMP-gated current. NO released from amacrine cells raises [cGMP] (Sagar, 1986), inducing the cGMP-gated current (Ahmad et al., 1994). Ganglion cells express Gi/o-coupled metabotropic receptors (shown by aquestion mark), such as GABAB (Zhang et al., 1997) and D2-dopamine receptor (Djamgoz and Wagner, 1992). Unidentified link is shown with a broken arrow.GLU, Glutamate; R, G-protein-coupled receptor; G, Gi or Goprotein.

Given that the suppression by AMPA of the cGMP-gated current acts via a non-NMDA ionotropic glutamate receptor, can the family be identified? Probably, it is the AMPA family (GluR1–4) because of the following: (1) ganglion cells express mRNA for these subunits most strongly (Hamassaki-Britto et al., 1993); (2) the concentrations of AMPA (10–100 μm) were insufficient to activate native kainate receptors (Lerma et al., 1993; Clarke et al., 1997; Huettner, 1997); and (3) the effect was blocked by GYKI-52466, which is relatively specific for AMPA receptors. Which particular AMPA subunits (GluR1–4) suppress the cGMP-gated current cannot be determined until their specific agonists and antagonists become available.

AMPA receptors on CNS neurons desensitize rapidly (Colquhoun et al., 1992; Raman and Trussell, 1992; Seeburg, 1993). Therefore, it surprised us that, as in previous reports on mammalian retina (Cohen et al., 1994; Sasaki and Kaneko, 1996), puff-applied AMPA causes little obvious desensitization. However, the time course of our puff application is slow compared with the rapid-flow method (Colquhoun et al., 1992; Raman and Trussell, 1992) used to study desensitization. If our ganglion cells desensitize in milliseconds, we would not see the effect. Another possibility is that ganglion cells might express an alternatively spliced “flip” module of the AMPA receptor, which desensitizes more slowly than a receptor containing both “flip” and “flop” modules (Sommer et al., 1990; Seeburg, 1993). Finally, a heteromer of AMPA subunits (GluR1–4) and kainate subunits (GluR5–7 and KA1/2) might resist desensitization.

How the AMPA receptor couples to the G-protein remains to be established. Seven transmembrane receptors, including the mGluRs, contain a cytoplasmic tail with a conserved amino acid sequence that binds the G-protein (Nakanishi, 1992; Hille, 1994; Riedel, 1996; Pass, 1998). However, the AMPA receptor is assembled from hetero-oligomers that lack such a sequence (Sommer et al., 1990; Nakanishi, 1992;Seeburg, 1993; Pass, 1998), so the AMPA receptor probably does not affect the G-protein directly. Because there are now three examples in which AMPA and kainate receptor families use a G-protein to trigger a biochemical cascade (adenylyl cyclase, Wang et al., 1997; phospholipase C, Rodriguez-Moreno and Lerma, 1998; PDE, present study), it will be important to identify the coupling mechanism.

Approximately half of the recorded ganglion cells expressed the cGMP-gated current, and all of these showed the AMPA-induced suppression. We identified ganglion cells in the slice by their location (ganglion cell layer) and large size (compared with displaced amacrine cells) but did not study their morphology. It will now be interesting to determine which type(s) of ganglion cell express this mechanism and to learn its role in visual processing. Possibly, NO amacrine cells increase the cGMP-gated inward current of a ganglion cell and thus enhance spiking. In a preliminary experiment, we indeed observed that 8-bromo-cGMP had this effect. Glutamate from bipolar cells can suppress the cGMP-gated current to briefly curtail these extra spikes. Thus, the metabotropic action of the AMPA receptor might contribute to suppress excitation from the NO amacrine cells. Naturally, there are other possibilities, but this one emphasizes what may be a general mechanism in many brain regions: that glutamate can antagonize a key excitatory effect of NO.

Footnotes

  • This work was supported by National Institutes of Health Grant EY00828. We thank N. Vardi, S. Zigmond, P. Liebman, D. Manning, S. Nawy, and A. Kaneko for comments; R. Smith, M. Freed, L. Haarsma, J. Demb, and J. Tanaka for technical advice; and S. Watanabe for technical advice on the slice preparation.

    Correspondence should be addressed to Dr. Fusao Kawai, c/o Dr. Peter Sterling, 123 Anatomy/Chemistry Building, Department of Neuroscience, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6058.

REFERENCES

  1. ↵
    1. Ahmad I,
    2. Leinders-Zufall T,
    3. Kocsis JD,
    4. Shepherd GM,
    5. Zufall F,
    6. Barnstable CJ
    (1994) Retinal ganglion cells express a cGMP-gated cation conductance activatable by nitric oxide donors. Neuron 12:155–165.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Aizenman E,
    2. Frosch MP,
    3. Lipton SA
    (1988) Responses mediated by excitatory amino acid receptors in solitary retinal ganglion cells from rat. J Physiol (Lond) 396:75–91.
    OpenUrlPubMed
  3. ↵
    1. Clarke VR,
    2. Ballyk BA,
    3. Hoo KH,
    4. Mandelzys A,
    5. Pellizzari A,
    6. Bath CP,
    7. Thomas J,
    8. Sharpe EF,
    9. Davies CH,
    10. Ornstein PL,
    11. Schoepp DD,
    12. Kamboj RK,
    13. Collingridge GL,
    14. Lodge D,
    15. Bleakman D
    (1997) A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. Nature 389:599–603.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Cohen ED,
    2. Zhou ZJ,
    3. Fain GL
    (1994) Ligand-gated currents of α and β ganglion cells in the cat retinal slice. J Neurophysiol 72:1260–1269.
    OpenUrlPubMed
  5. ↵
    1. Coleman PA,
    2. Miller RF
    (1998) Do N-methyl-d-aspartate receptors mediate synaptic responses in the mudpuppy retina? J Neurosci 8:4728–4733.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Colquhoun D,
    2. Jonas P,
    3. Sakmann B
    (1992) Action of brief pulses of glutamate on AMPA/kainate receptors in patch from different neurons of rat hippocampal slices. J Physiol (Lond) 458:261–287.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Danziger RS,
    2. Star RA,
    3. Matsumoto S,
    4. Coca-Prados M,
    5. DeSantis L,
    6. Pang IH
    (1993) Characterization of soluble guanylyl cyclase in transformed human non-pigmented epithelial cells. Biochem Biophys Res Commun 195:958–962.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Djamgoz MB,
    2. Wagner HJ
    (1992) Localization and function of dopamine in the adult vertebrate retina. Neurochem Int 20:139–191.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Donevan SD,
    2. Rogawski MA
    (1993) GYKI-52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron 10:51–59.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Fratelli M,
    2. Delgado R,
    3. Zinetti M,
    4. Galli G,
    5. Rolland Y,
    6. Ghezzi
    (1995) Chlorpromazine inhibits nitric oxide-mediated increase in intracellular cGMP in a mouse teratocarcinoma cell line. Inflamm Res 44:287–290.
    OpenUrlCrossRefPubMed
  11. ↵
    1. Hamassaki-Britto DE,
    2. Hermans-Borgmeyer I,
    3. Heinemann S,
    4. Hughes TE
    (1993) Expression of glutamate receptor genes in the mammalian retina: the localization of GluR1 to GluR7 mRNAs. J Neurosci 13:1888–1898.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Hamill OP,
    2. Marty A,
    3. Neher E,
    4. Sakmann B,
    5. Sigworth FJ
    (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391:85–100.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Hille B
    (1994) Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci 17:531–536.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Huettner JE
    (1997) Functional properties of kainate receptors. in The ionotropic glutamate receptors, eds Monaghan DT, Wenthold RJ (Humana, Totowa, NJ), pp 265–283.
  15. ↵
    1. Kaupp UB,
    2. Koch K-W
    (1992) Role of cGMP and Ca2+ in vertebrate photoreceptor excitation and adaptation. Annu Rev Neurosci 54:153–175.
    OpenUrl
  16. ↵
    1. Koutalos Y,
    2. Yau K-W
    (1996) Regulation of sensitivity in vertebrate rod photoreceptors by calcium. Trends Neurosci 19:73–81.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Lamb TD,
    2. Pugh EN Jr.
    (1992) G-protein cascades: gain and kinetics. Trends Neurosci 15:291–298.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Leinders-Zufall T,
    2. Rand MN,
    3. Waxman SG,
    4. Kocsis JD
    (1994) Differential role of two Ca2+-permeable non-NMDA glutamate channels in rat retinal ganglion cell: kainate-induced cytoplasmic and nuclear Ca2+ signals. J Neurophysiol 72:2503–2516.
    OpenUrlPubMed
  19. ↵
    1. Lerma J,
    2. Paternain AV,
    3. Naranjo JR,
    4. Mellstrom B
    (1993) Functional kainate selective glutamate receptor in cultured hippocampal neurons. Proc Natl Acad Sci USA 90:11688–11692.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Matsui K,
    2. Hosoi N,
    3. Tachibana M
    (1998) Excitatory synaptic transmission in the inner retina: paired recording of bipolar cells and neurons of the ganglion cell layer. J Neurosci 18:4500–4510.
    OpenUrlPubMed
  21. ↵
    1. Milligan G
    (1988) Techniques used in the identification and analysis of function of pertussis toxin-sensitive guanine nucleotide binding proteins. Biochem J 255:1–13.
    OpenUrlFREE Full Text
  22. ↵
    1. Mittman S,
    2. Taylor WR,
    3. Copenhagen DR
    (1990) Concomitant activation of two types of glutamate receptor mediates excitation of salamander retinal ganglion cells. J Physiol (Lond) 428:175–197.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Nakanishi S
    (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258:597–603.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Nawy S,
    2. Jahr CE
    (1990) Suppression by glutamate of cGMP-activated conductance in retinal bipolar cells. Nature 346:269–271.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Oguni M,
    2. Shinohara H,
    3. Asano T,
    4. Kato K,
    5. Setogawa T
    (1996) Ontogeny of GTP-binding proteins, Gi and G(o), in rat retina. Histochem Cell Biol 106:235–240.
    OpenUrlPubMed
  26. ↵
    1. Pass Y
    (1998) The macro- and microarchitectures of the ligand-binding domain of glutamate receptors. Trends Neurosci 21:117–125.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Raman IM,
    2. Trussell LO
    (1992) The kinetics of the response to glutamate and kainate in neurons of the avian cochlear nucleus. Neuron 9:173–186.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Riedel G
    (1996) Function of metabotropic glutamate receptors in learning and memory. Trends Neurosci 19:219–224.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Rodriguez-Moreno A,
    2. Lerma J
    (1998) Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 20:1211–1218.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Sagar S
    (1986) NADPH-diaphorase histochemistry in the rabbit retina. Brain Res 373:153–158.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Sandell JH
    (1985) NADPH diaphorase cells in the mammalian inner retina. J Comp Neurol 238:466–472.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Sasaki T,
    2. Kaneko A
    (1996) l-glutamate-induced responses in OFF-type bipolar cells of the cat retina. Vision Res 36:787–795.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Seeburg PH
    (1993) The molecular biology of mammalian glutamate receptor channels. Trends Neurosci 16:359–365.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Shiells RA,
    2. Falk G
    (1990) The glutamate receptor of rod bipolar cells are linked to a cyclic GMP cascade via a G-protein. Proc R Soc Lond B Biol Sci 242:91–94.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Shiells RA,
    2. Falk G
    (1992) The glutamate-receptor linked cGMP cascade of retinal on-bipolar cell is pertussis and cholera toxin-sensitive. Proc R Soc Lond B Biol Sci 247:17–20.
    OpenUrlPubMed
  36. ↵
    1. Sommer B,
    2. Keinanen K,
    3. Verdoorn TA,
    4. Wisden W,
    5. Burnashev N,
    6. Herb A,
    7. Kohler M,
    8. Takagi T,
    9. Sakmann B,
    10. Seeburg PH
    (1990) Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 249:1580–1585.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    1. Stuart-Smith K,
    2. Warner DO,
    3. Jones KA
    (1998) The role of cGMP in the relaxation to nitric oxide donors in airway smooth muscle. Eur J Pharmacol 341:225–233.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Taylor WR,
    2. Chen E,
    3. Copenhagen DR
    (1995) Characterization of spontaneous excitatory synaptic currents in salamander retinal ganglion cells. J Physiol (Lond) 486:207–221.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Terashima T,
    2. Katada T,
    3. Oinuma M,
    4. Inoue Y,
    5. Ui M
    (1987) Immunohistochemical localization of guanine nucleotide-binding protein in rat retina. Brain Res 410:97–100.
    OpenUrlCrossRefPubMed
  40. ↵
    1. Tian N,
    2. Slaughter MM
    (1994) Pharmacological similarity between the retinal APB receptor and the family of metabotropic glutamate receptors. J Neurophysiol 71:2258–2268.
    OpenUrlPubMed
  41. ↵
    1. Vardi N,
    2. Matesic DF,
    3. Manning DR,
    4. Liebman PA,
    5. Sterling P
    (1993) Identification of a G-protein in depolarizing rod bipolar cells. Vis Neurosci 10:473–478.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Wang Y,
    2. Small DL,
    3. Stanimirovic DB,
    4. Morley P,
    5. Durkin JP
    (1997) AMPA receptor-mediated regulation of a Gi-protein in cortical neurons. Nature 389:502–504.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Wei J-Y,
    2. Cohen ED,
    3. Genieser H-G,
    4. Barnstable CJ
    (1998) Substituted cGMP analogs can act as selective agonists of the rod photoreceptor cGMP-gated cation channel. J Mol Neurosci 10:53–64.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Werblin FS
    (1978) Transmission along and between rods in the tiger salamander retina. J Physiol (Lond) 280:449–470.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Yamashita M,
    2. Wässle H
    (1991) Response of rod bipolar cells isolated from the rat retina to the glutamate agonist 2-amino-4-phosphonobutyric acid (APB). J Neurosci 11:2372–2382.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Yau K-W,
    2. Baylor DA
    (1989) Cyclic GMP-activated conductance of retinal photoreceptor cells. Annu Rev Neurosci 12:289–327.
    OpenUrlCrossRefPubMed
  47. ↵
    1. Zhang D,
    2. Sucher NJ,
    3. Lipton SA
    (1995) Co-expression of AMPA/kainate receptor-operated channels with high and low Ca2+ permeability in single rat retinal ganglion cells. Neuroscience 67:177–188.
    OpenUrlCrossRefPubMed
  48. ↵
    1. Zhang J,
    2. Shen W,
    3. Slaughter MM
    (1997) Two metabotropic γ-aminobutyric acid receptors differentially modulated calcium currents in retinal ganglion cells. J Gen Physiol 110:45–58.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

The Journal of Neuroscience: 19 (8)
Journal of Neuroscience
Vol. 19, Issue 8
15 Apr 1999
  • Table of Contents
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
AMPA Receptor Activates a G-Protein that Suppresses a cGMP-Gated Current
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
AMPA Receptor Activates a G-Protein that Suppresses a cGMP-Gated Current
Fusao Kawai, Peter Sterling
Journal of Neuroscience 15 April 1999, 19 (8) 2954-2959; DOI: 10.1523/JNEUROSCI.19-08-02954.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
AMPA Receptor Activates a G-Protein that Suppresses a cGMP-Gated Current
Fusao Kawai, Peter Sterling
Journal of Neuroscience 15 April 1999, 19 (8) 2954-2959; DOI: 10.1523/JNEUROSCI.19-08-02954.1999
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • AMPA
  • glutamate
  • ionotropic
  • metabotropic
  • G-protein
  • retina
  • rat

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation
  • Neural Correlates of Competing Fear Behaviors Evoked by an Innately Aversive Stimulus
  • Distinct Developmental Modes and Lesion-Induced Reactions of Dendrites of Two Classes of Drosophila Sensory Neurons
Show more ARTICLE
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.